Research & Development
24 June 2024 - Pre-clinical-stage pharmaceutical company MIRA Pharmaceuticals Inc (NASDAQ:MIRA) on Monday unveiled promising preclinical results for Ketamir-2, its oral ketamine analog.Unlike traditio...
24 June 2024 - Vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) announced on Monday that it has secured its second approval for IXCHIQ, its single-dose chikungunya vaccine.Health Canada a...
24 June 2024 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) announced on Monday that the European Medicines Agency (EMA) has accepted its application to expand the use of Jemperli (dostarl...
24 June 2024 - Eli Lilly and Company (NYSE: LLY), a United States-based pharmaceutical company, announced on Friday detailed results from the SURMOUNT-OSA phase three clinical trial, assessing tirzepa...
21 June 2024 - The US Food and Drug Administration (FDA) has allowed the expanded use of Sarepta Therapeutics' (SRPT.O) gene therapy, it was announced on Thursday.The therapy is focused on patien...
21 June 2024 - Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) said on Friday that it has submitted an extension application to the European Medicines Agency (EMA) for a new subcutaneous for...